肾移植患者死亡危险因素:基于大型方案活检登记的分析
该研究利用一个肾移植项目中有方案活检的892例患者队列,建立移植后3个月和12个月死亡风险评估的多变量Cox模型。观察最长11年(总计5227患者年,中位5.9年),10年患者生存率为78%,移植物丢失者生存更差,活体供肾者生存更优。模型识别出年龄、移植前心衰、心血管疾病与2型糖尿病评分、移植后尿路感染、排斥治疗、新发心衰、冠脉事件和恶性肿瘤等共同因素,并提供了列线图工具。
要点
- 移植后3个月和12个月死亡风险模型共同包含8个因素,涵盖受者年龄、心血管代谢疾病、感染、排斥治疗和恶性肿瘤。
- 10年患者生存率为78%,移植物丢失者生存更差,活体供肾移植者生存更优。
- 基于模型提供列线图,可个体化权衡降低生存的风险因素。
核心结论
- 识别出的因素提示肾移植患者移植前和移植后护理中需特别关注的重要领域。
- 基于模型提供的列线图可作为权衡个体风险的工具,这些风险可能贡献于生存率下降。
研究设计与样本
- 研究纳入2000至2007年间移植的892例患者,观察长达11年(总计5227患者年,中位5.9年),失访15例。
- 共进行2251次方案活检和1214次指征活检,所有方案活检中的排斥和临床临界排斥均接受治疗。
- 采用多变量Cox模型建立移植后3个月和12个月的风险评估,并进行内部验证和独立队列(n=349)验证。
主要发现
- 总体10年患者生存率为78%,移植物丢失者生存更差,活体供肾移植者生存更优。
- 3个月和12个月模型共有的8个因素包括:年龄、移植前心衰、心血管疾病与2型糖尿病评分、移植后尿路感染、排斥治疗、新发心衰、冠脉事件和恶性肿瘤。
- 3个月模型额外变量包括尸体供肾移植、移植后淋巴囊肿、BK病毒肾病和严重感染。
- 12个月模型中移植物功能和移植物丢失是显著因素。
- 内部验证和独立队列(n=349)验证显示模型区分度良好。
临床怎么用
- 可利用列线图在移植前和移植后对患者个体死亡风险进行量化评估。
- 对携带共同风险因素(如心血管疾病、糖尿病、感染、排斥治疗、恶性肿瘤)的患者应加强关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identification and quantification of the relevant factors for death can improve patients' individual risk assessment and decision-making. We used a well-documented patient cohort (n = 892) in a renal transplant programme with protocol biopsies to establish multivariable Cox models for risk assessment at 3 and 12 months post-transplantation. METHODS: Patients transplanted between 2000 and 2007 were observed up to 11 years (total observation 5227 patient-years; median 5.9 years). Loss to follow-up was negligible (n = 15). A total of 2251 protocol biopsies and 1214 biopsies for cause were performed. All rejections and clinical borderline rejections in protocol biopsies were treated. RESULTS: Overall 10-year patient survival was 78%, with inferior survival of patients with graft loss and superior survival of patients with living-donor transplantation. Eight factors were common in the models at 3 and 12 months, including age, pre-transplant heart failure and a score of cardiovascular disease and type 2 diabetes, post-transplant urinary tract infection, treatment of rejection, new-onset heart failure, coronary events and malignancies. Additional variables of the model at 3 months included deceased donor transplantation, transplant lymphocele, BK virus nephropathy and severe infections. Graft function and graft loss were significant factors of the model at 12 months. Internal validation and validation with a separate cohort of patients (n = 349) demonstrated good discrimination of the models. CONCLUSIONS: The identified factors indicate the important areas that need special attention in the pre- and post-transplant care of renal transplant patients. On the basis of these models, we provide nomograms as a tool to weigh individual risks that may contribute to decreased survival.
引用
- Abeling T, Scheffner I, Karch A, et al. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. Nephrol Dial Transplant. 2019. PMID: 29860340. doi:10.1093/ndt/gfy131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。